The Success of Covid Antiviral Pills Depends on Quick Access and

JoNel Aleccia, Kaiser Health News In a matter of weeks, perhaps before many Americans finish decorating for the holidays, the US may have access to a new antiviral pill that Merck is expected to change the deadly course of the covid-19 pandemic – with a second option from Pfizer shortly thereafter. . Now under federal …